Supriya Lifescience (NSE:SUPRIYA) ROE % Adjusted to Book Value: 6.56% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SUPRIYA Supriya Lifescience Ltd NSE:SUPRIYA
80 GF Score
Price ₹852.40
GF Value ₹811.57
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Supriya Lifescience ROE % Adjusted to Book Value?

Supriya Lifescience NSE:SUPRIYA -2.10% 80 ROE % Adjusted to Book Value is 6.56% as of Mar. 2026. GuruFocus rates NSE:SUPRIYA with a GF Score™ of 80/100 and a GF Value™ of ₹811.57 (Fairly Valued). The stock has 3 warning signs investors should review.

Supriya Lifescience's ROE % for the quarter that ended in Mar. 2026 was 24.79%. Supriya Lifescience's PB Ratio for the quarter that ended in Mar. 2026 was 3.78. Supriya Lifescience's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 6.56%.

Supriya Lifescience ROE % Adjusted to Book Value Related Terms

Supriya Lifescience ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Supriya Lifescience's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Supriya Lifescience ROE % Adjusted to Book Value Chart

Supriya Lifescience Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROE % Adjusted to Book Value
Get a 7-Day Free Trial 5.32 6.24 4.78 3.50 5.04

Supriya Lifescience Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.41 0.00 3.44 0.00 6.56

NSE:SUPRIYA vs VRTX, REGN, ALNY: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Supriya Lifescience's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Supriya Lifescience ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Supriya Lifescience's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Supriya Lifescience's ROE % Adjusted to Book Value falls into.


NSE:SUPRIYA
80GF Score
Supriya Lifescience Ltd NSE:SUPRIYA
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Supriya Lifescience ROE % Adjusted to Book Value Calculation

Supriya Lifescience's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=19.06% / 3.78
=5.04%

Supriya Lifescience's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=24.79% / 3.78
=6.56%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 6.56% mean?
Supriya Lifescience (NSE:SUPRIYA) has a ROE % Adjusted to Book Value of 6.56% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Supriya Lifescience and its competitors.
Is Supriya Lifescience's ROE % Adjusted to Book Value too high?
Supriya Lifescience's current ROE % Adjusted to Book Value is 6.56%. Overall, Supriya Lifescience has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Supriya Lifescience's ROE % Adjusted to Book Value compare to VRTX and REGN?
Supriya Lifescience's ROE % Adjusted to Book Value of 6.56% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Supriya Lifescience and its competitors. Supriya Lifescience's current ROE % Adjusted to Book Value is 6.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Supriya Lifescience stock overvalued right now?
Based on GuruFocus' analysis, Supriya Lifescience (NSE:SUPRIYA) is currently considered Fairly Valued. The stock's GF Value™ is ₹811.57, compared to a current price of ₹852.40 — trading 5% above its estimated fair value. The current ROE % Adjusted to Book Value is 6.56%. Supriya Lifescience's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Supriya Lifescience (NSE:SUPRIYA), the current ROE % Adjusted to Book Value is 6.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Supriya Lifescience (NSE:SUPRIYA) Overvalued in 2026?

Based on GuruFocus' analysis, Supriya Lifescience stock appears to be overvalued. The current stock price of ₹852.40 is trading 5% above its estimated GF Value™ of ₹811.57. GuruFocus considers Supriya Lifescience to be Fairly Valued.

Key valuation signals for NSE:SUPRIYA:

  • ROE % Adjusted to Book Value: 6.56%
  • GF Value™: ₹811.57 vs. price of ₹852.40 (5% above fair value)
  • GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the NSE:SUPRIYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Supriya Lifescience Business Description

Other Exchanges 543434:India
Address Sonawala Road, 207/208, Udyog Bhavan, Goregaon East, Mumbai, MH, IND, 400063
Supriya Lifescience Ltd is a manufacturer of Active Pharmaceutical Ingredients. It is focused on diverse therapeutic segments such as antihistamines, analgesics, anaesthetics, vitamins, anti-asthmatic, and anti-allergic.
80GF Score

Get the complete analysis for NSE:SUPRIYA

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹852.40
Price
₹811.57
GF Value